Peptides DB
Research-centric peptide and protocol reference hub

Ovagen (EDL) record · updated 20h ago

Metabolic & appetiteHealing & recoveryGrade B · human evidenceResearch use only
All 7 studiesJump to the evidenceCompare
What is Ovagen (EDL) used for?

Ovagen (EDL) is a Khavinson-family tripeptide bioregulator researched for liver and gastrointestinal tissue support, proposed to act via gene-expression modulation in hepatocytes and enterocytes.

How it works: gene expression modulation in hepatocytes and enterocytes

Primarily researched for · Metabolic & appetite

Development stage

where Ovagen (EDL) sits between preclinical work and regulatory approval
  1. 1Current
    Preclinical
    Animal / in-vitro work
  2. 2Not reached
    Phase 1
    Safety in humans
  3. 3Not reached
    Phase 2
    Efficacy signal
  4. 4Not reached
    Phase 3
    Confirmatory trials
  5. 5Not reached
    Approved
    Cleared by a regulator

Stage is inferred from the highest trial phase in the indexed corpus. It describes the research record, not a recommendation.

Identity
NameOvagen (EDL)
Chain length—
Molecular weight—
Formula—
Structure type—
ClassMetabolic
Research levelLimited Research
Discovered byCurated master list · 2026
Pharmacology
Mechanismgene expression modulation in hepatocytes and enterocytes
Route—
Half-life—
Time to peak—
Duration—
Extraction confidence0.50
Effect profile · 0–5
These seven scores are generated by the Librarian — an autonomous agent running GPT-4o over the indexed studies, trials and label data for this compound. No human assigns them and no community vote moves them. Last recomputed Jul 29, 2026. How this works →
Research stats
Total studies7
Human / animal / cellular3 / 4 / 0
Highest trial phase—
Years covered2023–2025
Latest study28d ago
Publication history
20232025
Research funding
—no NIH grants found
Safety signals
FAERS reportsnone recorded
Serious AEs in animal work—
Community reports—
Positive —Neutral —Negative —
Records

Study register

7 rowsOpen in the library →
StudyTypeYearSummary depth
Melatonin improves the vitrification of sheep morulae by modulating transcriptome.
FindingNot reported in abstract.
Animal2023Full text read0.70
Reviving vacuum-dried encapsulated ram spermatozoa via ICSI after 2 years of storage.
Finding12.8% embryonic development in VDE vs 8.7% in FD, p<0.001
Animal2023Full text read0.80
The Choice of Osteosynthesis for Distal Radius Fractures: A Matter of Taste, Fracture Instability, or Patient-Related Factors? A Retrospective Study of Functional Outcome in 346 Distal Radius Fractures Operated With Percutaneous Wires or Volar Plate Fixation.
FindingNot reported in abstract.
Human2024Full text read0.80
Electroporation Delivery of Cas9 sgRNA Ribonucleoprotein-Mediated Genome Editing in Sheep IVF Zygotes.
FindingKnock-in efficiency of 26% for MSTN gene targeting.
Animal2024Full text read0.70
Evaluation of Quality of Life, Anxiety, and Depression in Patients with Primary Axillary Hyperhidrosis Undergoing Treatment with a Microwave Device: One-year Follow-up.
Finding88.2% of patients achieved a Hyperhidrosis Disease Severity Scale score of 2 or less at 1 year, n=103.
Human2024Full text read0.70
A Novel Method to Sterilize Isolators for the Housing of Germ-Free Birds and Production of Germ-Free Eggs.
FindingValues >1440 ppm-h cycle achieved in this study provided consistently adequate antimicrobial efficacy.
Animal2025Full text read0.70
Cone-Beam Computed Tomography Influences the Classification and Choice of Treatment for Distal Radius Fractures.
Finding38% (n=57) of the observations had a change in suggested treatment when CBCT was used.
Human2025Full text read0.80

What people are saying

anecdotal · not evidence

Unverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching Ovagen (EDL) will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.

Community collection has not run yet, so this is an empty shelf rather than a quiet one — nothing has been read, and no conclusion about how much Ovagen (EDL) is discussed should be drawn from it.